Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Adverum Biotechnologies Inc. | 9 | 0 | 1 | 0 | €1.38 | €20.55 | 1388.986% |
| ProQR Therapeutics N.V. | 8 | 2 | 0 | 0 | €1.73 | €3.03 | 75.704% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €40.60 | €50.00 | 23.153% |
| R1 RCM Inc. | 23 | 0 | 4 | 0 | €11.80 | €17.21 | 45.869% |
| iRhythm Technologies Inc | 13 | 0 | 1 | 0 | €87.50 | €121.75 | 39.148% |
| Rocket Pharmaceuticals Inc | 2 | 1 | 0 | 0 | ? | €32.00 | 34.172% |
| Pro-Dex Inc. | 12 | 0 | 0 | 0 | €17.20 | - | - |
| Rhythm Pharmaceuticals | 16 | 0 | 1 | 0 | €45.60 | €46.37 | 1.689% |
| Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
| Nektar Therapeutics | 4 | 1 | 1 | 0 | €1.26 | €2.40 | 90.627% |
| Merck & Co. Inc. | 30 | 1 | 0 | 0 | €115.40 | €124.97 | 8.296% |
| Catalyst Pharmaceutical Partners Inc | 13 | 0 | 0 | 0 | €16.20 | €24.44 | 50.882% |
| Drägerwerk AG & Co. KGaA ST | 3 | 0 | 1 | 0 | €45.60 | €66.00 | 44.737% |
| EssilorLuxottica SA | 3 | 0 | 0 | 0 | €206.30 | €204.50 | -0.873% |
| Novo Nordisk A/S | 5 | 0 | 1 | 0 | €185.00 | €195.00 | 5.405% |
| Fresenius Medical Care AG & Co KGaA ST | 3 | 0 | 0 | 0 | €37.24 | €50.00 | 34.264% |
| Trinity Biotech ADR | 27 | 0 | 3 | 0 | €0.41 | - | - |
| Immutep LTD ADR | 1 | 0 | 0 | 0 | €1.97 | €4.00 | 103.046% |
| Verastem Inc. | 12 | 0 | 2 | 0 | €2.72 | €17.56 | 545.441% |
| Xeris Biopharma Holdings Inc. | 6 | 0 | 0 | 0 | €2.40 | €4.39 | 82.971% |
| Abbott Laboratories | 19 | 0 | 1 | 0 | €96.93 | €116.25 | 19.929% |
| UCB S.A. | 1 | 0 | 0 | 0 | €152.65 | - | - |
| Cigna Corp. | 21 | 0 | 2 | 0 | €316.50 | €356.77 | 12.725% |
| Perrigo Co. plc | 4 | 0 | 0 | 0 | €25.89 | €35.01 | 35.208% |
| Vertex Pharmaceuticals Inc. | 55 | 2 | 5 | 0 | €456.30 | €450.36 | -1.301% |